Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.
Fujii T, Salanti G, Belletti A, Bellomo R, Carr A, Furukawa TA, Luethi N, Luo Y, Putzu A, Sartini C, Tsujimoto Y, Udy AA, Yanase F, Young PJ. Fujii T, et al. Among authors: udy aa. Intensive Care Med. 2022 Jan;48(1):16-24. doi: 10.1007/s00134-021-06558-0. Epub 2021 Nov 9. Intensive Care Med. 2022. PMID: 34750650 Free PMC article.
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Udy AA, Paul SK, Lipman J; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian Society for Infectious Diseases Clinical Research Network. Dulhunty JM, et al. Among authors: udy aa. Crit Care Resusc. 2013 Sep;15(3):179-85. Crit Care Resusc. 2013. PMID: 23944203 Clinical Trial.
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J; BLING II Investigators for the ANZICS Clinical Trials Group *. Dulhunty JM, et al. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1298-305. doi: 10.1164/rccm.201505-0857OC. Am J Respir Crit Care Med. 2015. PMID: 26200166 Clinical Trial.
Subarachnoid Hemorrhage Patients Admitted to Intensive Care in Australia and New Zealand: A Multicenter Cohort Analysis of In-Hospital Mortality Over 15 Years.
Udy AA, Vladic C, Saxby ER, Cohen J, Delaney A, Flower O, Anstey M, Bellomo R, Cooper DJ, Pilcher DV; Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation. Udy AA, et al. Crit Care Med. 2017 Feb;45(2):e138-e145. doi: 10.1097/CCM.0000000000002059. Crit Care Med. 2017. PMID: 27749342
Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit.
Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, Pilcher DV; Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Raith EP, et al. Among authors: udy aa. JAMA. 2017 Jan 17;317(3):290-300. doi: 10.1001/jama.2016.20328. JAMA. 2017. PMID: 28114553
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
Udy AA, Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J; BLING-II Investigators; ANZICS Clinical Trials Group. Udy AA, et al. Int J Antimicrob Agents. 2017 May;49(5):624-630. doi: 10.1016/j.ijantimicag.2016.12.022. Epub 2017 Mar 9. Int J Antimicrob Agents. 2017. PMID: 28286115 Clinical Trial.
The impact of disability in survivors of critical illness.
Hodgson CL, Udy AA, Bailey M, Barrett J, Bellomo R, Bucknall T, Gabbe BJ, Higgins AM, Iwashyna TJ, Hunt-Smith J, Murray LJ, Myles PS, Ponsford J, Pilcher D, Walker C, Young M, Cooper DJ. Hodgson CL, et al. Among authors: udy aa. Intensive Care Med. 2017 Jul;43(7):992-1001. doi: 10.1007/s00134-017-4830-0. Epub 2017 May 22. Intensive Care Med. 2017. PMID: 28534110
Erratum to: The impact of disability in survivors of critical illness.
Hodgson CL, Udy AA, Bailey M, Barrett J, Bellomo R, Bucknall T, Gabbe BJ, Higgins AM, Iwashyna TJ, Hunt-Smith J, Murray LJ, Myles PS, Ponsford J, Pilcher D, Walker C, Young M, Cooper DJ. Hodgson CL, et al. Among authors: udy aa. Intensive Care Med. 2017 Dec;43(12):1938. doi: 10.1007/s00134-017-4937-3. Intensive Care Med. 2017. PMID: 28916987
The case for more pilot studies.
Luethi N, Udy A. Luethi N, et al. Crit Care Resusc. 2017 Dec;19(4):285-286. Crit Care Resusc. 2017. PMID: 29202252 No abstract available.
251 results